The global oculoplastic surgery market is expected to grow at a CAGR of around 5.82% from 2019 to 2026 and expected to reach the market value of around US$ 10,686.6 Mn by 2026.
A general term used for procedures performed around the eyelid, orbit, and/or face is eye plastic surgery or oculoplastic surgery. Oculoplastic surgery is generally performed to improve the overall appearance of patients. Oculoplastic surgery is plastic surgery in regions such as eyelids, eyelids, facial tear ducts. Anomalies such as eye abnormalities, eye socket trauma, thyroid disease, orbital disease, and tearing problems are corrected in-order. Oculoplastic surgeons are ophthalmologists specialized in periorbital and facial tissue plastic and reconstructive surgery involving eyelids, eyebrows, nose, cheeks, orbit (bony cavity around the eye) and lacrimal (tear) systems. Factors such as advances in non-invasive techniques due to benefits, including rapid recovery time and the same-day procedure, are expected to boost the market.
The global oculoplastic surgery market is expected to have an increased prevalence of eye-related disorders, such as blurred vision, eye wrinkles, and droopy eyes are expected to contribute to market growth.
According to the American Society of Aesthetic Plastic Surgery, more than 1.3 million eyelid operations were conducted worldwide in 2018. Increased medical tourism and enhanced reimbursement policies are projected to have a positive impact on the growth of the oculoplastic surgery industry in both developed and developing economies in the foreseeable future. Other factors driving the market growth are increased disposable income, increased acceptance of various oculoplastic surgeries, and willingness to spend on aesthetic surgery. Social media and celebrities in the medical aesthetics industry have proven to be a strong influence on consumers. For example, according to multiple studies in the UK, about 55% of facial plastic surgeons reported that patients in their practice had been motivated by a desire to look better in selfies in 2017, up from 13% in 2016. In addition, there is a growing demand for medical aesthetic procedures provided by beauty salons with a constant plea to upgrade to more reliable and efficient aesthetic equipment in the UK. The advent of minimally invasive surgical procedures, however, may limit the presence during the forecast period for oculoplastic surgeries.
By procedure, the eyelid surgery segment dominated the oculoplastic surgery market
On the basis of procedure, the market is segmented into eyelid surgery, face lift, brow lift & forehead lift, pediatric oculoplastic surgery, and others. In 2018, the eyelid surgery segment is expected to dominate the market. The eyelid surgery removes excess skin from the upper eyelid and reduces bagginess from the lower eyelid. Increasing geriatric population prone to various problems with vision impairment and issues such as lowering the upper eyelids are expected to drive segment growth in the coming years.
The market research study on “Oculoplastic Surgery Market– Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”, offers a detailed insight into the global oculoplastic surgery market entailing insights on its different market segments. Market dynamics with drivers, restraints, and opportunities with their impact are provided in the report. The report provides insights into the global oculoplastic surgery market, its procedure, end user, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global oculoplastic surgery market size and volume, and segment markets by procedure, end user, and geography along with the information on companies operating in the market. The oculoplastic surgery market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market size and volume for different segments have been covered under the scope of the report.
In 2018, North America dominated the regional market with a maximum market share
North America are accounted for the highest share of the global oculoplastic surgery market during the forecast period. The market in this region is growing due to the high volume of procedures and the high cost of treatment. North America has had a large adjustable population in the last four years alone with a thousand-year aesthetic user rate tripled in the U.S. and further dominated the regional market for oculoplastic surgery in the same year due to high number of procedures in the country. Blepharoplasty-removal of excess tissue around the eyelids is one of the most common cosmetic procedures performed in the world, according to the American Society of Aesthetic Plastic Surgeons. In 2018, 115,000 blepharoplasty procedures were performed in the United States. This expected to further influence the growth in the region during the forecast period. Moreover, the Asia Pacific is expected to showcase the highest growth rate in the market over the forecast period.
The main companies involved in the global oculoplastic surgery market are Integra Life Sciences, Sklar Surgical Instruments, TEKNO-MEDICAL Optik-Chirurge GmbH, Stanford Health Care, Zimmer Biomet holdings Inc., B. Braun Melsungen AG, Blink Medical Ltd, Shoyukai, Bolton Surgical Ltd, Karlz Storz, and BMT Medizintechnik GmbH. The companies are involved in mergers and acquisitions and new procedure development for expanding their market share and also for gaining competitive advantages over its competitors.
Market By Procedure
Market By End user
Market By Geography
Oculoplastic surgery is generally performed to improve the overall appearance of patients.
Factors such as advances in non-invasive techniques due to benefits, including rapid recovery time and the same-day procedure, are expected to boost the market.
Factors such as an increased prevalence of eye-related disorders, such as blurred vision, eye wrinkles, and droopy eyes the oculoplastic surgery market growth.
According to Acumen Research and Consulting, the oculoplastic surgery market value is anticipated to be worth around US$ 10,686.6 million in 2026.
The oculoplastic surgery market is anticipated to grow over 5.82% CAGR during the forecast period 2019 to 2026
North America held maximum share in 2018 for oculoplastic surgery market.
Life Sciences, Sklar Surgical Instruments, TEKNO-MEDICAL Optik-Chirurge GmbH, and Stanford Health Care are the top players operating in the oculoplastic surgery market.